New wipe could stop armpit sweat in its tracks
NCT ID NCT02129660
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested two different medicated wipes (glycopyrrolate and glycopyrronium) against a placebo wipe for people with excessive underarm sweating. 105 adults used the wipes once daily for 4 weeks, then stopped for 2 weeks. Researchers measured sweat production and how much sweating affected daily life to see if the wipes helped.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
glycopyrrolate and glycopyrronium topical wipes
What this could lead to
If successful, this could lead to a new prescription wipe that reduces excessive underarm sweating with daily use.
What could go wrong
This is an early Phase 2 trial with only 105 people, so results may not apply to everyone. The treatment is for symptom control, not a cure, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERHIDROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
California Dermatology & Clinical Research Institute
Encinitas, California, 92024, United States
-
Center For Dermatology Clinical Research
Fremont, California, 94538, United States
-
DermResearch, Inc
Austin, Texas, 78759, United States
-
Dermatology Associates
Seattle, Washington, 98101, United States
-
Dermatology Research Center, Inc.
Salt Lake City, Utah, 84117, United States
-
Haber Dermatology and Cosmetic Surgery
Beachwood, Ohio, 44122, United States
-
Innovaderm Research Inc.
Montreal, H2K 4L5, Canada
-
Kenneth R. Beer MD
West Palm Beach, Florida, 33401, United States
-
Olympian Clinical Research
Tampa, Florida, 33609, United States
-
Premier Clinical Research
Spokane, Washington, 99204, United States
-
Rivergate Dermatology Clinical Research Center, PLLC
Goodlettsville, Tennessee, 37072, United States
-
Saint Louis University Dermatology
St Louis, Missouri, 63122, United States
-
Shideler Clinical Research Center
Carmel, Indiana, 46032, United States
-
Virginia Clinical Research, Inc.
Norfolk, Virginia, 23507, United States
-
Women's Clinical Research Center
Seattle, Washington, 98105, United States